Logo

FTC Clears Danaher's Proposed Acquisition of Beckman Coulter

Mar 10, 2011

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The US Federal Trade Commission has granted early termination of the review period for Danaher's proposed $6.8 billion acquisition of Beckman Coulter, according to a notice posted on the agency's website today.

The firms had announced the deal in early February, and at the time said they expected to complete the transaction in the first half of 2011.

Beckman recently reported that its fiscal-year 2010 revenues increased 12 percent to $3.66 billion. Its operations would be added to Danaher's Life Sciences & Diagnostics division, which posted 2010 revenues of $2.3 billion.

Filed under

Beckman Coulter
Danaher
FTC clearance
mergers & acquisitions
FTC
Breaking News
The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.